Skip to content

Sodium zirconium cyclosilicate

Lokelma (sodium zirconium cyclosilicate) is a small molecule pharmaceutical. Sodium zirconium cyclosilicate was first approved as Lokelma on 2018-03-22. It is used to treat hyperkalemia in the USA. It has been approved in Europe to treat hyperkalemia. Lokelma's patents are valid until 2035-10-14 (FDA).
Trade Name Lokelma
Common Name Sodium zirconium cyclosilicate
Indication hyperkalemia
Drug Class Quaternary ammonium derivatives
Sodium zirconium cyclosilicate
Get full access now